Skip to content

Dr. Marc Bloquiaux

Active
Private limited companyfounded 2005active for 21 yearsKortrijkseweg 351, 8791 Waregem, BelgiumKBO/BCE: BE 0871.625.964

From the official registers: KBO 21 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Marc Bloquiaux has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €472,622 and a net result of €121,599. Equity has been growing by about 34% per year since 2018. Its solvency ranks better than 82% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Dr. Marc BloquiauxActiveChecked score 97/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 02-02-2005 Normal situation
Legal form
Private limited company
Registered office
Kortrijkseweg 351, 8791 Waregem
Activity
General medical practice NACE 86210and 1 other
Financial year end
31 December
Peppol
Reachable since 03-02-2026
Company details

Board and ownership

Board
Board & ownership

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€191,458
▲ 12.1%
Turnover
≈ €350,000
estimated
Profit
€121,599
▲ 15.3%
Equity
€472,622
▲ 26.0%
Total assets
€531,918
▲ 26.6%
2025 accounts filed 28 days after the deadline
Filed on 28-08-2026at the National Bank
Financials
Score breakdownraises riskLast filed accounts filed 28 days late; 1 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 8.19, cash €287,501Equity €472,622 (88.9% of total assets)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 75% of micro companies in human health (NACE 86)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 100=
equity 88.9% of total assets
Liquidity 100=
short-term debt 10.7% · cash 54.0%
Profitability 97-3
return on assets 22.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 8.19 (8.03 in 2024), above the usual 1.5. Short-term debt is 10.7% and cash 54% of total assets. 11.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 90% on liquidity, 57% on profitability and 69% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 8.19, cash €287,501
NBB · annual accounts
lowers risk · Equity €472,622 (88.9% of total assets)
NBB · annual accounts
raises risk · Last filed accounts filed 28 days late; 1 of the last 3 accounts late
NBB · filings
raises risk · 2025 accounts filed 28 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
28 days late
2024
25 days late
2023
53 days late
2022
29 days late
2021
27 days late
2020
5 days early
2019
4 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 22 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 82% of companies in human healthsector median 63.0% · 20,678 companies 88.9% View
  • Positive: 8 profitable years in a rowprofit 2025: €121,599 8 years View
  • Positive: Equity rose in 2025from €374,963 to €472,622 ▲ 26.0% View

Documents

Annual accounts at the NBB

All 21 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. Marc Bloquiaux

What is the company number of Dr. Marc Bloquiaux?
The company number of Dr. Marc Bloquiaux is 0871.625.964. The VAT number is the same number with BE in front: BE 0871.625.964.
Where is Dr. Marc Bloquiaux based?
The registered office is at Kortrijkseweg 351, 8791 Waregem.Company details
What does Dr. Marc Bloquiaux do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Marc Bloquiaux?
The legal form of Dr. Marc Bloquiaux is Private limited company (BV).
When was Dr. Marc Bloquiaux founded?
Dr. Marc Bloquiaux was founded on 02-02-2005.
Is Dr. Marc Bloquiaux still active?
Yes, Dr. Marc Bloquiaux is an active enterprise in the KBO register.
What is the turnover of Dr. Marc Bloquiaux?
The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €191,458 and 30 comparable companies (NACE 86210). It probably lies between €280,000 and €430,000.Financials
Is Dr. Marc Bloquiaux profitable?
In financial year 2025, Dr. Marc Bloquiaux made a profit of €121,599.
Where can I find the annual accounts of Dr. Marc Bloquiaux?
Dr. Marc Bloquiaux filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Marc Bloquiaux due?
Dr. Marc Bloquiaux must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as Dr. Marc Bloquiaux: general medical practice (NACE 86210). They are comparable in size and age: total assets between €476,000 and €557,000, founded between 2001 and 2007.

CompanyTotal assetsGross margin
Dr. Marc Bloquiaux Waregem€531,918€191,458
CAUDRON HILDE DOKTERSVENNOOTSCHAP Wielsbeke€518,203€194,093
CLAERHOUT G. Kortrijk€475,557€183,942
Dr. IRIS KNOCKAERT Brugge€550,224€173,881
DECLOEDT HUISARTSENPRAKTIJK Zonnebeke€556,827€186,905
DR. BENE VANBESIEN Poperinge€542,540€170,254
IDEMMED Chapelle-lez-Herlaimont€507,675€201,258
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure